483
Surmasis Pharmaceutical, LLCFDA 483 - Surmasis Pharmaceutical, LLC - August 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Surmasis Pharmaceutical, LLC in Des Moines, IA, a combination drug/device manufacturer, received a Form 483 with four observations. The inspection revealed significant deficiencies in the firm's quality system, including a repeat observation regarding the investigation of unexplained discrepancies. Additionally, the firm failed to segregate non-conforming materials and lacked proper management review and a written quality plan for its combination products.
Open in Dashboard
ID · a9754776-fa7b-407d-9e77-3850f1791576